Literature DB >> 30452542

Association Between Maternal Iodine Intake in Pregnancy and Childhood Neurodevelopment at Age 18 Months.

Shao J Zhou1,2, Dominique Condo3, Philip Ryan4, Sheila A Skeaff5, Stuart Howell4, Peter J Anderson6,7, Andrew J McPhee8, Maria Makrides9.   

Abstract

There are limited and inconsistent data suggesting that mild iodine deficiency in pregnancy might be associated with poorer developmental outcomes in children. Between 2011 and 2015, we conducted a prospective cohort study in Australia examining the relationship between maternal iodine intake in pregnancy and childhood neurodevelopment, assessed using Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), in 699 children at 18 months. Maternal iodine intake and urinary iodine concentration (UIC) were assessed at study entry (<20 weeks' gestation) and at 28 weeks' gestation. Maternal iodine intake in the lowest (<220 μg/day) or highest (≥391 μg/day) quartile was associated with lower cognitive, language, and motor scores (mean differences ranged from 2.4 (95% confidence interval (CI): 0.01, 4.8) to 7.0 (95% CI: 2.8, 11.1) points lower) and higher odds (odds ratios ranged from 2.7 (95% CI: 1.3, 5.6) to 2.8 (95% CI: 1.3, 5.7)) of cognitive developmental delay (Bayley-III score <1 SD) compared with mothers with an iodine intake in the middle quartiles. There was no association between UIC in pregnancy and Bayley-III outcomes regardless of whether UIC and the outcomes were analyzed as continuous or categorical variables. Both low and high iodine intakes in pregnancy were associated with poorer childhood neurodevelopment in this iodine-sufficient population.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30452542     DOI: 10.1093/aje/kwy225

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

Review 1.  Assessment and treatment of thyroid disorders in pregnancy and the postpartum period.

Authors:  Sun Y Lee; Elizabeth N Pearce
Journal:  Nat Rev Endocrinol       Date:  2022-01-04       Impact factor: 47.564

2.  Maternal Iodine Intake and Neurodevelopment of Offspring: The Japan Environment and Children's Study.

Authors:  Aya Hisada; Rieko Takatani; Midori Yamamoto; Hiroko Nakaoka; Kenichi Sakurai; Chisato Mori
Journal:  Nutrients       Date:  2022-04-27       Impact factor: 6.706

Review 3.  Minerals in Pregnancy and Their Impact on Child Growth and Development.

Authors:  Patricia Miranda Farias; Gabriela Marcelino; Lidiani Figueiredo Santana; Eliane Borges de Almeida; Rita de Cássia Avellaneda Guimarães; Arnildo Pott; Priscila Aiko Hiane; Karine de Cássia Freitas
Journal:  Molecules       Date:  2020-11-30       Impact factor: 4.411

4.  Iodine status in pregnant women and infants in Finland.

Authors:  Elizabeth A Miles; Tero Vahlberg; Philip C Calder; Noora Houttu; Lotta Pajunen; Ella Koivuniemi; Kati Mokkala; Kirsi Laitinen
Journal:  Eur J Nutr       Date:  2022-03-19       Impact factor: 4.865

Review 5.  Association Between Newborn Thyroid-Stimulating-Hormone Concentration and Neurodevelopment and Growth: a Systematic Review.

Authors:  Molla Mesele Wassie; Lisa Gaye Smithers; Shao Jia Zhou
Journal:  Biol Trace Elem Res       Date:  2021-03-08       Impact factor: 3.738

6.  Associations between maternal thyroid function in pregnancy and child neurodevelopmental outcomes at 20 months in the Seychelles Child Development Study, Nutrition Cohort 2 (SCDS NC2).

Authors:  Anna M Monaghan; Maria S Mulhern; Emeir M Mc Sorley; J J Strain; Theresa Winter; Edwin van Wijngaarden; Gary J Myers; Philip W Davidson; Conrad Shamlaye; Jude Gedeon; Alison J Yeates
Journal:  J Nutr Sci       Date:  2021-08-31

7.  Iodine Nutrition and Iodine Supplement Initiation in Association with Thyroid Function in Mildly-to-Moderately Iodine-Deficient Pregnant and Postpartum Women.

Authors:  Synnøve Næss; Maria W Markhus; Tor A Strand; Marian Kjellevold; Lisbeth Dahl; Ann-Elin M Stokland; Bjørn G Nedrebø; Inger Aakre
Journal:  J Nutr       Date:  2021-10-01       Impact factor: 4.798

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.